OUR BEST FRIENDS

whs-logo

http://www.wsdtc.org/

The Sergei Foundation

shelterpet_logo

B-more Dog

aldflogo

Pinups for Pitbulls

philadoptables

TFPF_Logo

Mid Atlantic Pug Rescue

Our Pack, Inc.

Maine Coonhound Rescue

Saving Shelter Pets, Inc.

mabb

LD Logo Color

Tag: clone

When selling technology gets out ahead of understanding technology

cartoon6

When the marketing of a new technology gets ahead of refining that technology, and finding its best use, it can be disastrous.

But, biotech being what it is, and greed being what it is, it happens — a lot: Let’s start selling it before we fully understand it, much less the repercussions it might bring.

Dog cloning is one example of that. Canine genetic testing — now being marketed by some companies — might well be another.

Promising uses may exist in both technologies, but the rush to market them, the gullibility of humans, and the total lack of oversight and restrictions governing their use, have resulted in a whole new market niche — selling false hope.

With both, claims have been made that can’t be backed up. With both, the marketing claims can’t be confirmed by scientific evidence, at least in amounts most scientist deem acceptable to serve as proof. With both, the zeal to put a product or service on the marketplace has led to many outrageous claims and more than a few “woops” moments.

71VI6KUzxML._SL1500_DNA testing of dogs has become a booming business in the last 10 years, starting with the marketing of tests that promised to determine what breeds are in your dog — a fun little method of solving they mystery of a dog’s heritage by testing its blood or saliva in a lab.

Companies said then that knowing what breeds make up your dog could also be a way of keeping him or her healthy, and allow you to watch out for certain diseases and disorders that those breeds are prone to.

In more recent years, it has been used to test for genetic mutations, making it, seemingly, a more valuable diagnostic tool for veterinarians.

Today, it can be used to make life or death decisions and that, a commentary piece in the journal Nature warned last week, is a mistake.

At least it appeared to be a mistake for a little dog named Petunia.

Petunia, 13, started having trouble walking and controlling her bladder and bowels last year.

91Wg3qmDurL._SL1500_Her owners bought a $65 home genetic test, and the results showed their pug carried a mutation that is linked to a neurodegenerative condition similar to the human disease ALS — one that would lead to paralysis and eventual death.

Based on that, her owners had her put down.

What they might not have realized is that as few as 1 in 100 dogs that test positive for the common mutation develop the rare disease. Petunia’s condition could have been the result of a more-treatable spinal disorder.

“Genetic testing for pets is expanding,” the Nature article said. “Hundreds of thousands of dogs have now been genetically screened, as Petunia was, and companies are beginning to offer tests for cats. But the science is lagging. Most of these tests are based on small, underpowered studies. Neither their accuracy nor their ability to predict health outcomes has been validated. Most vets don’t know enough about the limitations of the studies, or about genetics in general, to be able to advise worried owners.

“Pet genetics must be reined in. If not, some companies will continue to profit by selling potentially misleading and often inaccurate information; pets and their owners will suffer needlessly; and opportunities to improve pet health and even to leverage studies in dogs and cats to benefit human health might be lost. Ultimately, people will become more distrustful of science and medicine.”

71aDTs6xiFL._SL1440_What’s not to be trusted here, though, is the marketing.

Claims are made before there is enough science to back them up, and we — minds boggled by all the indecipherable advances in technology around us — accept them.

Few of us really understand, and nobody — I’d argue — bothers much to look at the repercussions, to where it might all lead.

That’s what makes this Nature commentary exceptional. It was written by Lisa Moses, a veterinarian at the MSPCA-Angell Animal Medical Center in Boston and a research scholar on bioethics at Harvard, along with two other Boston-based experts.

Petunia’s case, she said, “is one, but there have been many of them. In fact, a number of cases just like that one are what started me thinking about this years ago, when the first genetic tests started to be used routinely.”

Co-author Elinor Karlsson, a researcher on dog genetics based at the UMass Medical School and the Broad Institute, said she was “aghast” when she learned from Moses that genetic research like hers is being used to make clinical decisions — including euthanasia.

“It really upset me,” she said. “Both the idea that people were already using genetics like this and the idea that the papers that I’ve published on things like bone cancer and compulsive disorder may also end up being used as tests, and that people wouldn’t understand what the limitations were of the work that we’ve done so far.”

The article calls for several remedies, including quality standards for how pet genetic tests are performed, how results are shared, and counselors who could help owners interpret results.

“One of the purposes of this article was just a heads-up to everybody that this needs some serious attention in an organized fashion,” said Veterinarian Steven Niemi, who co-authored the Nature commentary and is the director of the Office of Animal Resources at Harvard.

“We shall sell no wine before its time,” a wine-making company once boasted, hiring Orson Welles to voice those words in a TV ad. Of course, it wasn’t true. Gallo specialized in cheaper wines — Thunderbird even.

Nevertheless, it is advice those who are marketing technology might do well to take, at least if they want to come anywhere close to gaining the public’s trust. For the public, my advice would be don’t do it; wait for the proof.

An understandable, but still wrong, case of dog cloning

Most people who get their dogs cloned — whether they are Barbra Streisand or a non-celebrity — do so in a misguided attempt to hang on, if not to that dog, at least to its memory.

A Michigan woman had a slightly different reason: She cloned her daughter’s dog to hang on to her daughter’s memory.

And, however much sympathy that might evoke, however difficult this is to say, that’s still every bit as misguided.

Photographer Monnie Must, who has spent her career capturing memories, lost her eldest daughter, Miya, to suicide almost 11 years ago.

Must took over the care of Miya’s two dogs, Henley and Billy Bean.

As the 10th anniversary of Miya’s death approached, Henley passed away. Billy, a black Lab, was about to turn 14.

“Billy was her (Miya’s) soul and the thought of losing her was more than I could possibly bear,” she said.

“I thought, I am going to clone her,” Must told Fox 2 in Detroit. “I don’t know where it came from. It wasn’t like I was reading about it, I just thought I am going to clone her.”

Must began researching what it would take to clone Billy, and ended up in contact with a U.S. company called PerPETuate, the only U.S. company offering the service. The cloning was accomplished in a lab operated by Viagen, a company that primarily clones livestock.

Two vials of tissue were taken from Billy, and scientists merged Billy’s cells with egg cells of of another dog, creating an embryo with Billy’s exact DNA.

That was implanted into a surrogate dog at a Rochester, N.Y., lab operated by Viagen.

Last October, they called to tell her they were going to do an ultrasound on Oct. 11 — Miya’s birthday.

“It’s like, really? Of all the dates?” Must said.

Eight weeks after the birth of the dog, named Gunni, Must, who lives in Sylvan Lake, Mich., flew to Rochester to pick her up.

“There was like an immediate bond between us, this dog. I just adore this dog.”

Now eight months old, Gunni’s appearance and personality strike her as identical to those of Billy.

“Billy was kind of a wild, crazy, happy dog – and Gunni is kind of a wild, crazy, happy dog and she is smart,” she said. “So all I can see so far.”

And here is where I need to stop and point out a few things.

Cloned dogs don’t always have the exact appearance as the original, and a “personality” match is even less likely. Often, when they do, it’s because surplus dogs have also been cloned. Souls, I’d respectfully argue, are not transferable. How many puppies have you known that aren’t wild, crazy and happy? What did Must really pay $50,000 for, and could not an equally similar dog been found at her local shelter?

Grief can lead us to do strange things — and that is what those who invented and marketed the service have counted on since the bump-filled beginning.

(You can read about that bumpy beginning in my book, “Dog, Inc.”)

PerPETuate reported on its that Facebook page that the dogs are physically similar, but that Gunni was not initially getting along with Billy Bean, the donor dog, who is still alive.

gunniandbilly“Billy Bean was envious of Gunni and would like to have had her out of the house! After weeks of sensitive management Billy and Gunni are sharing space and beginning to form a close relationship.”

Must says Gunni is “perfect” and that having her in her life has reduced her anxiety.

“A lot of people have feelings – is this right, is this wrong?” she said. “For me, this is what was going to make me function.” Those who would criticize her, she said, “are not in that position. You can’t walk in someone’s shoes. I hope no one else has to walk in those shoes.”

One never feels fully whole again after losing a child, she says, but with Gunni at her side she is able to feel joy again.

As one who can relate to that, I’m happy she found a pathway to joy, even though — sadly — it was not the right one.

Chinese scientists clone the world’s first primate; two macaque monkeys are born

monkeys_16x9leashes1

Nearly 13 years after the cloning of a dog, the species man is emotionally closest to, Chinese scientists have announced the first successful cloning of the animal man is physically closest to — the monkey.

Using the same basic technique that created Dolly the sheep in Scotland, the world’s first cloned mammal, and Snuppy the Afghan hound in South Korea, scientists in China produced two identical clones of a macaque, reigniting concerns among some that attempts to clone man are on the horizon.

The newborns — the world’s first cloned primates — were named Zhong Zhong and Hua Hua, after a Mandarin term for the Chinese nation and people.

The two healthy baby macaques were the only ones to survive to birth out of 127 altered egg cells implanted into more than 60 surrogate mothers.

The scientists behind the project said they followed the techniques of somatic cell nuclear transfer, but made a few refinements along the way. Unlike with Dolly and Snuppy, fetal cells were used rather than adult ones

Mu-ming Poo, director of the Chinese Academy of Sciences’s Institute of Neuroscience in Shanghai, who led the work, said further refinement of their methods would lead to higher success rates, Combining the cloning with gene editing will allow researchers to create “ideal nonhuman primate models” for studying disease mechanisms and screening drugs, he said.

So in answer to the seldom asked (at least by scientists) question — why clone monkeys? — that’s your immediate answer: As fodder for laboratory experiments.

The team behind the monkey cloning acknowledges that the work raises ethical questions, but Poo said he doubted it would lead to cloning man: “I would think society and the general public and governments will not allow extension of this method from nonhuman primates to humans.”

Science magazine reports that ethicists are also concerned about the monkeys themselves. “At present, it has not been sufficiently demonstrated that there are no alternatives to using macaque monkeys for such research,” Peter Dabrock, an ethicist at Friedrich-Alexander University in Erlangen, Germany, wrote in a statement.

Using nonhuman primates for research is more accepted in China than in the West, Poo said, adding “Once we demonstrate the cloned monkey’s usefulness in curing disease, I hope [Western societies] will gradually change their minds.”

He said the group is following international guidelines for the treatment and care of their monkeys.

Scientists around the world have cloned more than 20 species since Dolly the sheep was created in 1996, including dog, cat, horses, pigs, cows, rabbits, rats and mice,

Attempts to clone primates, however, had been unsuccessful, and some experts suspected primates might be resistant to the procedure.

The Chinese team reported in the Feb. 8 edition of the journal Cell that it’s difficult, but possible. The team succeeded, after many attempts, by using modulators to switch on or off certain genes that were inhibiting embryo development.

In all, it took more than 100 egg cells — merged with donor cells and implanted into surrogates — to produce two live macaque births.

Using adult cells, they achieved 22 pregnancies in 42 surrogates. That produced two births but neither survived. When they cloned using fetal monkey cells, six pregnancies were confirmed in 21 surrogates and yielded two healthy babies.

While the scientists celebrate their achievement, animal welfare groups, including PETA, condemned it.

“Cloning is a horror show: A waste of lives, time, and money – and the suffering that such experiments cause is unimaginable,” said Dr. Julia Baines, Science Policy Adviser at PETA UK. “Because cloning has a failure rate of at least 90 per cent, these two monkeys represent misery and death on an enormous scale.”

(Photo: Qiang Sun and Mu-ming Poo/Chinese Academy of Sciences)

Chinese scientists clone dogs with heart disease — and call it an achievement

longlong

China says it has managed to join South Korea as a world leader in canine cloning — by managing to create a clone of a sick dog.

Longlong, a beagle, was born with a blood-clotting disorder, and that was just what the scientists were hoping for.

The pup is a clone of Apple, a different dog whose genome was edited to develop the disease atherosclerosis, CNN reported.

longlong1By cloning the bioengineered dog, the scientists ensured they will have a good supply of diseased dogs for experiments they say could lead to cures for the condition that causes strokes and heart disease in humans.

Longlong was created by the Beijing-based biotech company Sinogene, which is boasting about having created the world’s first dog cloned from a gene-edited donor.

With Longlong’s birth, and two more clones of the bio-engineered dog being born since then, the scientists claimed that China had matched South Korea as a leader in canine cloning technology. South Korean scientists cloned the first dog, an Afghan hound named Snuppy, in 2005.

“Dogs share the most inheritable diseases with human beings, which makes them the best disease models to study,” says Feng Chong, technical director at Sinogene.

While the pups haven’t shown any signs of cardiovascular disease yet, their cloning ensures they will get it. Experimental drugs to treat cardiovascular diseases are already being tested on them.

Longlong’s birth combined two technologies: A gene-editing tool called CRISPR with somatic cell cloning technology, the method used to clone Dolly the sheep and later, Snuppy.

Zhao Jianping, vice manager of Sinogene, says the company’s success in dog cloning is about 50%. Two surrogate dogs out of four gave birth to three cloned puppies. The other two did not get pregnant.

Scientists at Sinogene believe their work aids the future of pharmaceutical development and biomedical research and it plans to produce more cloned dogs like Longlong.

“Gene-edited dogs are very useful for pharmaceutical companies,” said Feng. “The supply falls short of the demand every year.”

(Poor little pharmaceutical companies.)

The scientists also say cloning bio-engineered dogs to create puppy clones that will be born with the disease is kinder than the previous method of creating atherosclerosis in lab dogs — namely, force feeding with meals high in sugar.

Scientists, in case you haven’t noticed, have also invented a way to justify just about anything they want to do.

So if you want to hail this as a great achievement in technology, go ahead. I prefer to see it as scientists taking another giant stride toward playing God — giveth-ing life to dogs, only to taketh it away. Mankind may benefit (or at least live a longlong time), but rest assured the biggest gains will go to pharmaceutical companies.

(Photos: CNN)

South Korean university announces that Snuppy has been recloned

reclonedsnuppy

The world’s first canine clone — an Afghan hound named Snuppy who died in 2015 — has been recloned, scientists at Seoul National University in Korea have announced.

It’s no big surprise, and it’s no huge achievement, but the scientists say they created the three clones of Snuppy to “immortalize” the “milestone” Snuppy represented — and that the clones will allow them to further study the lifespan of cloned dogs.

Snuppy, who spent most of his life in a laboratory, died at age 10 in April 2015.

“Three healthy reclones of Snuppy are alive, and as with Snuppy we do not anticipate that the reclones will go through an accelerated rate of aging or will be more prone to develop diseases than naturally bred animals,” the team wrote in Scientific Reports, a journal from the publishers of Nature.

To create the new clones, the scientists used fat-derived stem cells taken from Snuppy when he was five years old.

The stem cells were taken from his belly fat and frozen. Years later, they were thawed, grown in culture and then injected into enucleated eggs taken from female donors. The reconstituted eggs were then zapped with an electrical shock to fuse the membranes of the egg and stem cells. Ninety-four of them were transferred to surrogate female dogs.

Four resulted in births, but one of the pups died four days after it was born from severe diarrhea, the scientists reported.

The three remaining dogs will also live their lives in the lab, being monitored and undergoing tests the scientist say they suspect will dispel the notion that cloned animals die early deaths.

They say the second generation of Snuppy clones will contribute to a “new era” in the study of the health and longevity of cloned animals, and that they might contribute to cures being found for human diseases.

But with dog cloning having become big business — and having been initially researched with profits in mind — it’s no surprise that the latest research, funded in part by the Korean government, aims to dispel the thinking that clones live abbreviated lives.

Snuppy’s birth came eight years after Dolly the sheep became the first cloned mammal in 1997. Dolly died prematurely, at age six.

Snuppy

Snuppy

When Snuppy was born in 2005, Time magazine named him one of the most amazing inventions of the year. What wasn’t reported much, at least not initially, were the intrusive procedures involved, the birth defects that resulted, the surplus dogs that resulted, and the long list of animal welfare concerns about the process.

In the article written in Scientific Reports, by the researchers involved, those concerns also get short shrift.

“Animal cloning has gained popularity as a method to produce genetically identical animals or superior animals for research or industrial uses,” they write.

“There is lots of pet cloning going on right now. Owners are concerned whether their clones will live (a normal lifespan) or if they will experience accelerated aging and die early. So, there is some business concern,” said said co-author of the study CheMyong Jay Ko, of the University of Illinois.

The clones of Snuppy might also provide insights into the development of cancer and other diseases, Ko said.

(Top photo from the National Post; bottom of photo by John Woestendiek)

To read more about the birth of dog cloning and how it became a big business, read John Woestendiek’s book, “Dog, Inc.

Chinese lab produces what it says is the world’s first “superdog” clone

longlong4

Chinese scientists say they have produced a “superdog” clone — and that the technology will enable them to mass produce dogs that are extra strong and extra fast.

And, unless you are a fan of the doggy version of eugenics, you might find that extra scary.

The beagle, named Long Long, was born in May, becoming one of China’s first canine clones and, the scientist’s maintain, the world’s first genetically modified canine clone.

“This is a breakthrough, marking China as only the second country in the world to independently master dog-somatic clone technology, after South Korea,” said Lai Liangxue, a researcher of Guangzhou Institute of Biological Medicine and Health with the Chinese Academy of Science.

The beagle puppy was genetically engineered by deleting a gene called myostatin, giving him double the muscle mass of a normal beagle.

longlongHe was one of 27 puppies created at Sino Gene, a biotech company based in Beijing — all clones of a laboratory research dog named Apple, according to published reports.

The researchers created 65 embryos through cloning, and genetically modified all of them.

Only Long Long had his myostatin deleted.

By combining genetic editing and cloning, scientists say they can produce “superbreeds” that are stronger and faster.

“With this technology, by selecting a certain gene of the dog, we can breed an animal with more muscles, better sense of smell and stronger running ability, which is good for hunting and police applications,” Lai said.

He also suggested that the gene-editing technology could be commercialized and further applied to create dogs with diseases such as autism, Parkinson’s and diabetes, for use in medical research.

It’s just the latest chapter in dog cloning, which has a frightening history and, potentially, an even scarier future.

Efforts to clone dog began in the U.S., with early research at Texas A&M funded by backers who saw cloning people’s pets — often sick, dying or even dead — as a profitable business enterprise.

Canine cloning wasn’t achieved until a few years later at Seoul National University in South Korea when Snuppy, the world’s first canine clone, was born in 2005.

The service would be offered to pet owners by several businesses, only one of which remains, Sooam Bioengineering Research Institute, the laboratory of controversial South Korean scientist Hwang Woo Suk.

longlong2Twelve years would pass before China became the second country to clone dogs — and clone them with a twist.

Lai says his team will be able to “batch produce” customized dogs through cloning and gene-editing, which in addition to possible military and law enforcement uses, would create an endless supply of dogs for use in laboratories by medical researchers.

The researcher has worked for years on genetically modifying dogs. By mastering cloning, and combining it with his gene-editing, he’s able to endlessly duplicate any successes he achieves.

As with Dolly the sheep and Snuppy the dog, Lai’s achievement is seen as ominous by some.

“It’s true that the more and more animals that are genetically engineered using these techniques brings us closer to the possibility of genetic engineering of humans,” David King, director of Human Genetics Alert, told the Express..

“That does set us on the road to eugenics,” King added. “I am very concerned with what I’m seeing.”

Me, too. Dog cloning raises some significant animal welfare concerns. Technology, especially when coupled with greed or ego, tends to run amok. Eugenics is a nightmarish pursuit, as is its canine version. Creating diseased dogs for medical research is just plain wrong.

On top of all that, this latest twist being touted by the Chinese researchers fails to recognize one simple fact:

Dogs are already super.

(Photos: Sino Gene)

Dog clones: Now made in America

nubia2

Just as the earliest efforts to clone a dog in America didn’t make a huge splash, news-wise, neither did the recent birth — nearly 20 years later — of the first made-in-America canine clone.

ViaGen, a genetic preservation company in Texas, announced at the end of July that the first successful cloning of a dog in America had led to a birth, and that the Jack Russell terrier pup had been delivered to clients.

Chances are you haven’t read about it — because hardly anyone has written about it.

Including me — the guy who wrote that dog cloning book.

I received an email Monday containing the press release announcing the successful cloning. It came from Andrew Lavin, a public relations consultant in New York who handles publicity for ViaGen. It was dated Sept. 12 and included the photos of the clone, named Nubia, that you see here.

When I checked online to see what news coverage the announcement had received, I found almost none — only an “article” in Pet Age magazine (actually a verbatim reprint of the company press release) in July.

When I called ViaGen’s Austin offices to clear up some of my confusion I was told the press release had originally been issued at the end of July, and they didn’t know why the one I received had been re-dated to Sept. 12.

When I asked why the announcement had not received greater news coverage, the person on the phone said only, “It was a soft press release.” She didn’t explain what that meant.

(I can only guess it means a press release sent to a limited few, vague and fuzzy on the details, and accompanied by a “we’re not going to answer any questions” attitude — one that is low-profile enough to not arouse any detractors, such as the many animal welfare organizations that frown on cloning pets, saying it is cruel to animals and exploits bereaved pet owners.)

When I asked ViaGen for more information about the cloning, I was told, “all media requests go through Andy,” meaning Andrew Lavin.

He eventually returned my call and answered my email, explaining that he had “updated” the original press release — and therefore changed the date on it.

He did seek answers to my questions and sent me ViaGen CEO Blake Russell’s responses to them. Russell sidestepped far more than he answered.

nubia1The owners of the clone are not being identified — apparently not even the state or country where they reside.

Their original dog is deceased, but they were able to have her cloned with tissue samples taken by her vet when she was spayed.

Asked where the other dogs that are needed to produce a successful clone came from — dogs in heat from whom egg cells are harvested, and female dogs who serve as surrogates — Russell said ViaGen Pets purchases oocytes from an unnamed provider and that “ViaGen Pets uses a production partner to supply the needed surrogates.”

Presumably, the merging of egg and donor cells and the surgeries necessary were performed at ViaGen labs in Texas.

Texas, by the way, is where the whole crazy idea got started — though it wasn’t pulled off until scientists in South Korea cloned the world’s first dog.

Here’s the condensed version:

Shortly after the birth of the world’s first cloned mammal, Dolly the sheep, in 1996, the wealthy founder of the University of Phoenix, John Sperling, decided that cloning his girlfriend’s dog, Missy, would make for a lovely gift.

He teamed up with his girlfriend’s son, Lou Hawthorne, to find a learning institution that would be interested in cloning the world’s first dog.

They chose Texas A&M University and funneled millions into the project.

For years, from 1998 to 2002, researchers there tried to clone a dog. They were able to clone the world’s first pig, cat, bull and goat, but dogs, they found, were extra difficult.

Hawthorne had high hopes of turning the cloning of pet dogs into a big business, and it was during this time that he launched Genetic Savings & Clone, a company that, like Viagen, stored the cells of pets whose owners thought they might someday want a clone.

Snuppy

Snuppy

The research project at Texas A&M, eventually, was dropped, but the quest was picked up by Seoul National University in South Korea, which produced the first dog clone, Snuppy, in 2005.

The thousands produced since then — most often for bereaved pet owners seeking a duplicate of the dog they lost — have all been made in South Korean laboratories.

At one point, two Korean companies were producing dog clones for customers, and one American company was selling dog cloning, too.

Bio Arts, a company Hawthorne started in hopes of cloning dogs on its own, ended up teaming up with one of the Korean companies, Sooam, led by former Seoul National University scientist Hwang Woo Suk, to provide clones to American customers.

Among the first of those shipped back to the U.S. was a clone of Missy, which he presented to his mother, Sperling’s girlfriend.

She noted the puppy was ill-behaved, and said she didn’t want it.

SONY DSC

Surgery at Sooam

Hawthorne later pulled out of the partnership with Sooam, citing, among other reasons, his concerns that accepted animal welfare protocols — or at least those accepted by most Western countries — weren’t being followed by the South Koreans.

“A cloned dog contributes to the happiness of a family but I do not think it is possible to do it without a huge amount of suffering to hundreds of others,” Hawthorne told The Mirror, which was reporting on the first dog cloning for a customer in the UK.

In an interview with the Mirror, Hawthorne referred to the vast numbers of dogs that it took — up to 80, he said — to clone just one. And he confirmed that, as my book reported, Korean cloning researchers borrowed dogs from dog farms — farms where dogs are raised for their meat — for the process.

Today, only one of the Korean companies is still in operation.

https://www.amazon.com/Dog-Inc-Uncanny-Inside-Cloning/dp/1583333916Another Korean company that paved the way for cloning pet dogs — and provided the first clones to an American customer — pulled out of cloning pet dogs in 2011, not long after the publication of my book, “DOG, INC: The Uncanny Inside Story of Cloning Man’s Best Friend.”

ViaGen’s successful cloning of a dog lessens the likelihood of dog cloning fading away; instead it brings the process to American shores, and offers it at a much reduced price — $50,000 instead of the initial $150,000 the Korean companies charged.

ViaGen Pets says it is now the only American company offering pet cloning services — and says they are doing so “in full compliance with all U.S. regulatory standards and humane pet care practices.”

The are no federal laws against cloning dogs, or for that matter, humans, in the United States.

ViaGen,a long-time cloner of livestock, produced its first cloned cats for customers last year and it has been banking the cells of pets for more than a decade.

The company says the birth of Nubia will likely increase demand for cloning and genetic preservation of companion pet DNA.

screencapture-viagenpets-1473861354711

President Blake Russell said the company has already genetically preserved almost 1,000 pets and that there is a waiting list for the cloning procedure.

“The potential to have an identical twin to something that was very important and special in your life is an unprecedented opportunity and has brought a lot of joy to pet owners,” Russell says in the press release.

In addition to the cost of cloning, ViaGen charges a $1,600 fee and $150 a year to store tissue samples from pets whose owners may someday want to clone them.

The cloning procedure involves injecting cells harvested from the original dog into egg cells harvested from female dogs, a jolt of electricity to help them merge, and implanting the resulting embryo into a surrogate mother dog who carries the pup to birth.

ViaGen says a cloned puppy or kitten is “simply a genetic twin born at a later date, and should share many of the original’s attributes, including intelligence, temperament and appearance.”

The South Korean company guarantees only that the appearance will be identical, or nearly identical — but they often achieve that by producing multiple clones.

Many of dog cloning’s customers have come from the U.S. and the U.K. — and up to now they have been turning to Sooam Biotech to clone their dogs.

Most animal welfare organizations oppose the practice, pointing to the number of other dogs it takes to produce a clone, the intrusive procedures, the creation of surplus clones, and the sometimes nightmarish results. They also say pet cloning companies are exploiting the grief of bereaved pet owners.

There has been little outcry from them about the fact that dog cloning is now being done in America. Then again, it’s a development of which many people — possibly having missed that “soft” press release — aren’t aware.

In any case, it appears an American-born idea has finally — for better or worse — come to fruition in America.

(Photos of Nubia courtesy of ViaGen Pets; photos of Snuppy and a cloning underway at Sooam by John Woestendiek)